AIM
MRNA icon

Axiom Investment Management’s Moderna MRNA Stock Holding History

Axiom Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.6K Sell
866
-200
-19% -$10.3K 0.04% 200
2026
Q1 		$54.2K Buy
+1,066
New +$49.7K 0.04% 202
2022
Q4 		$269K Hold
1,500
– – 0.7% 48
2022
Q3 		$177K Buy
+1,500
New +$228K 0.35% 61

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Axiom Investment Management's MRNA Position: Q2 2026 in Review

Axiom Investment Management reduced its Moderna (MRNA) stake by 19% in Q2 2026, selling an estimated $10.3K and leaving 866 shares worth $60.6K. The position accounts for 0.04% of the portfolio, ranked #200.

Axiom Investment Management first reported a position in MRNA in Q3 2022 and has held it in 4 quarters since. The position peaked at $269K in Q4 2022. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Axiom Investment Management held 866 shares of Moderna worth $60.6K as of Q2 2026.
  • Axiom Investment Management sold 200 Moderna shares in Q2 2026, an estimated $10.3K.
  • Moderna made up 0.04% of Axiom Investment Management's portfolio in Q2 2026, its #200 holding.
  • Axiom Investment Management first reported a position in Moderna in Q3 2022 and has held it in 4 quarters since.
  • Axiom Investment Management's Moderna position peaked at $269K in Q4 2022.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.